Sigma Healthcare Limited (ASX:SIG)
Australia flag Australia · Delayed Price · Currency is AUD
2.825
+0.005 (0.18%)
Nov 9, 2026, 11:26 AM AEDT

Sigma Healthcare Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Sigma Healthcare stock has a consensus rating of "Buy" and an average price target of $3.15. The average 1-year stock price forecast is 11.40% higher than the current stock price, while the lowest is $2.70 (-4.42%) and the highest is $3.75 (+32.74%).

Price Target: $3.15 (+11.40%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.70$3.15$3.15$3.75
Change-4.42%+11.40%+11.50%+32.74%

Analyst Ratings

The average analyst rating for Sigma Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy889999
Buy332222
Hold445555
Sell000000
Strong Sell000000
Total151516161616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Maintains
$3.20 → $3.10
BuyMaintains$3.20 → $3.10+9.73%Oct 23, 2026
Jarden
Jarden
Buy
Maintains
$3.60 → $3.50
BuyMaintains$3.60 → $3.50+23.89%Oct 22, 2026
Jefferies
Jefferies
Buy
Maintains
$3.20 → $3.15
BuyMaintains$3.20 → $3.15+11.50%Oct 22, 2026
Ord Minnett
Ord Minnett
Buy
Maintains
$3.40 → $3.20
BuyMaintains$3.40 → $3.20+13.27%Oct 22, 2026
Unknown Analyst
Macquarie
No rating
Macquarie
Buy
Maintains
$3.20 → $3.10
BuyMaintains$3.20 → $3.10+9.73%Oct 21, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
12.20B
from 10.83B
Increased by 12.63%
Revenue Next Year
13.46B
from 12.20B
Increased by 10.32%
EPS This Year
0.08
from 0.06
Increased by 18.41%
EPS Next Year
0.09
from 0.08
Increased by 16.10%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
2.99B3.09B3.29B6.00B10.83B12.20B
Revenue Growth
23.67%3.27%6.59%82.18%80.53%12.63%
Gross Profit
1.07B917.70M1.04B1.44B1.96B2.27B
Gross Margin
35.83%29.69%31.66%24.00%18.06%18.57%
Operating Income
574.54M428.73M552.65M722.59M992.05M1.27B
Net Income
385.93M304.33M541.01M529.91M709.18M855.82M
EPS
----0.060.08
EPS Growth
----15.61%18.41%
Forward PE
---50.6837.3637.50
Dividend / Share
---0.010.040.05
Dividend Growth
----207.69%14.37%
Free Cash Flow
----517.91M731.67M
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202720282029
High12.5B
Avg12.2B
Low11.9B

Revenue Growth

Revenue Growth202720282029
High
15.1%
Avg
12.6%
Low
9.9%

EPS Forecast

EPS202720282029
High0.08
Avg0.08
Low0.07

EPS Growth

EPS Growth202720282029
High
25.7%
Avg
18.4%
Low
10.0%